BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 30, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

Tryton pushes forward with pivotal stent trial; completes enrollment

Nov. 27, 2012
By Omar Ford

Exact Sciences completes: enrollment for Deep-C trial

Nov. 20, 2012
By Omar Ford

Corus CAD gene expression test effective in elderly population

Nov. 19, 2012
By Omar Ford

Guided Therapeutics submits amended PMA for LuViva

Nov. 15, 2012
By Omar Ford

FI's powered artificial limb could pave way for neuroprosthetics

Nov. 12, 2012
By Omar Ford

NewCo on the Go: SpinalCyte uses cells instead of implants to treat degenerative disc

Nov. 9, 2012
By Omar Ford

Siemens launches application to help deal with hospital anxiety

Nov. 8, 2012
By Omar Ford

2012 Medical Innovation Summit: From implants to diagnostics, Zimmer's Dvorak discusses all

Nov. 7, 2012
By Omar Ford
CLEVELAND — Knee implants can be a tricky thing. On one hand, even though they can be done successfully – patients sometimes have significant concerns of how the implant feels. Last week, David Dvorak, Zimmer's (Warsaw, Indiana) CEO spoke to a crowded room at Cleveland Clinic's 2012 Medical Innovation Summit about this topic and several others during one of the final CEO one-on-ones of the conference.
Read More
Cc symbol only12

Rethinking Innovation

Nov. 5, 2012
By Omar Ford
If I had to sum up the key take away from Cleveland Clinic's Medical Innovation Summit last week, I would probably say something like this : Innovation is alive and well, but are hospitals and physicians willing to pay for it when capital is so strained? Nearly every panel that I attended seemed to have that as an underlying theme. Everyone from Cleveland Clinic's own Dr. Joseph Iannotti to Medtronic's CEO Omar Ishrak made statements about innovation in healthcare and the importance of having it present in an environment where capital is limited and dollars are few. Iannotti made...
Read More

2012 Medical Innovation Summit: Imaging Modalities continue to shape ortho-procedures

Nov. 5, 2012
By Omar Ford
CLEVELAND — There is no question that new imaging modalities have made a tremendous impact on current orthopedic procedures. During the closing day of Cleveland Clinic's 2012 Medical Innovation Summit, a panel talked about this impact as well as the integration of diagnostics and therapeutics in a session called New Imaging Modalities shaping Orthopedics.
Read More
Previous 1 2 … 119 120 121 122 123 124 125 126 127 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 29, 2026.
  • Illustration for mutations in the DNA leading to brain diseases or neurodegenerative disorders

    ENCALS 2026: From genetics to advancing strategies against ALS

    BioWorld Science
    Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
  • Handshake with DNA, molecules

    Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement

    BioWorld Science
    Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
  • Digital brain with dollar sign

    Investors bet on transformative BCI tech for neuro disorders

    BioWorld
    An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
  • Shanghai Yingli Pharmaceutical identifies new KRAS mutant inhibitors

    BioWorld Science
    Shanghai Yingli Pharmaceutical Co. Ltd. has discovered hydrazine-structured compounds as inhibitors of GTPase KRAS and its mutants. They are reported to be useful...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing